Literature DB >> 32623648

Systemic immune-inflammation index combined with ferritin can serve as a reliable assessment score for adult-onset Still's disease.

Ji-Won Kim1, Ju-Yang Jung1, Chang-Hee Suh1, Hyoun-Ah Kim2.   

Abstract

OBJECTIVE: The diagnosis of adult-onset Still's disease (AOSD) is based on nonspecific symptoms and laboratory data, and several infectious, autoimmune, and malignant diseases must be ruled out. This study aimed to elucidate the value of various laboratory inflammatory scores, including the systemic immune-inflammation index (SII), C-reactive protein/albumin ratio (CAR), albumin/globulin ratio (AGR), prognostic nutritional index (PNI), and ferritin/erythrocyte sedimentation rate ratio (FER) as assessment factors for diagnosis and evaluation of disease activity in AOSD.
METHODS: The medical records of patients suspected of AOSD between January 1999 and June 2019 were examined. The inflammatory scores were compared between AOSD and non-AOSD groups, and receiver operating characteristic (ROC) curve analysis was performed to evaluate diagnostic utility.
RESULTS: A total of 164 patients diagnosed with AOSD had higher values of SII, CAR, and FER, as well as lower values of AGR and PNI, than non-AOSD patients (n = 61). For an AOSD diagnosis, the area under the receiver operating characteristic curve (AUC) was 0.859 (95% confidence interval [CI], 0.806-0.911) for the SII, 0.769 (95% CI, 0.702-0.837) for the CAR, 0.749 (95% CI, 0.615-0.782) for the AGR, 0.699 (95% CI, 0.675-0.823) for the PNI, and 0.764 (95% CI, 0.693-0.834) for the FER, with optimal cut-off values of 2195.7, 1.8, 1.38, 48.8, and 17, respectively. The SII had the largest AUC and the highest specificity (91.5%). In further analysis, the AUC for the combination of SII and ferritin was 0.904 (95% CI, 0.863-0.945), with a cut-off value of 2615.4.
CONCLUSIONS: Laboratory inflammatory scores can be used as a practical tool for diagnosing AOSD. The SII and ferritin combination proved to be the most powerful assessment tool. Key Points • The systemic immune-inflammation index (SII), C-reactive protein/albumin ratio (CAR), ferritin/erythrocyte sedimentation rate ratio (FER), prognostic nutritional index (PNI), and albumin/globulin ratio (AGR) can be used as initial assessment scores for AOSD. • SII combined with ferritin (AUC = 0.904; 95% CI, 0.863-0.945) appears to be the most effective and valuable assessment score for AOSD.

Entities:  

Keywords:  Adult-onset Still’s disease; Ferritin; Systemic immune-inflammation index

Mesh:

Substances:

Year:  2020        PMID: 32623648     DOI: 10.1007/s10067-020-05266-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  3 in total

1.  Preliminary criteria for classification of adult Still's disease.

Authors:  M Yamaguchi; A Ohta; T Tsunematsu; R Kasukawa; Y Mizushima; H Kashiwagi; S Kashiwazaki; K Tanimoto; Y Matsumoto; T Ota
Journal:  J Rheumatol       Date:  1992-03       Impact factor: 4.666

2.  Neutrophil- and platelet-to-lymphocyte ratios are correlated with disease activity in rheumatoid arthritis.

Authors:  Haitao Fu; Baodong Qin; Zhide Hu; Ning Ma; Min Yang; Tingting Wei; Qingqing Tang; Yuanlan Huang; Fenglou Huang; Yan Liang; Zaixing Yang; Renqian Zhong
Journal:  Clin Lab       Date:  2015       Impact factor: 1.138

3.  The neutrophil-to-lymphocyte ratio could be a good diagnostic marker and predictor of relapse in patients with adult-onset Still's disease: A STROBE-compliant retrospective observational analysis.

Authors:  Ji-Yeoun Seo; Chang-Hee Suh; Ju-Yang Jung; Ar-Reum Kim; Ji Won Yang; Hyoun-Ah Kim
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

  3 in total
  9 in total

1.  New Inflammatory Marker Associated with Disease Activity in Rheumatoid Arthritis: The Systemic Immune-Inflammation Index.

Authors:  Serap Satis
Journal:  Curr Health Sci J       Date:  2021-12-31

2.  Could systemic immune inflammation index be a new parameter for diagnosis and disease activity assessment in systemic lupus erythematosus?

Authors:  Arzu Ozdemir; Erdem Baran; Muhammed Kutu; Selda Celik; Murvet Yılmaz
Journal:  Int Urol Nephrol       Date:  2022-08-02       Impact factor: 2.266

3.  Systemic Immune-Inflammation Index (SII) Predicts Increased Severity in Psoriasis and Psoriatic Arthritis.

Authors:  Ahu Yorulmaz; Yildiz Hayran; Umit Akpinar; Basak Yalcin
Journal:  Curr Health Sci J       Date:  2020-12-31

4.  Systemic immune-inflammation index is associated with disease activity in patients with ankylosing spondylitis.

Authors:  Junlai Wu; Lifang Yan; Kexia Chai
Journal:  J Clin Lab Anal       Date:  2021-08-21       Impact factor: 2.352

5.  Serum Immune-Inflammation Index Assessment in the Patients with Ulcerative Colitis.

Authors:  Zehra Betul Pakoz; Muge Ustaoglu; Sezgin Vatansever; Elif Saritas Yuksel; Firdevs Topal
Journal:  Gastroenterol Res Pract       Date:  2022-01-31       Impact factor: 2.260

6.  The Prognostic Significance of C-Reactive Protein to Albumin Ratio in Patients With Severe Fever With Thrombocytopenia Syndrome.

Authors:  Xiaozhou Yang; Huimin Yin; Congshu Xiao; Rongkuan Li; Yu Liu
Journal:  Front Med (Lausanne)       Date:  2022-04-29

7.  Increased TIGIT+PD‑1+CXCR5CD4+T cells are associated with disease activity in rheumatoid arthritis.

Authors:  Qing Luo; Peng Fu; Yongqin Guo; Biqi Fu; Yang Guo; Qingshui Huang; Zikun Huang; Junming Li
Journal:  Exp Ther Med       Date:  2022-08-31       Impact factor: 2.751

8.  Correlation between C-Reactive Protein to Albumin Ratio and Disease Activity in Patients with Axial Spondyloarthritis.

Authors:  Zheng Zhong; Yukai Huang; Yuqi Liu; Junming Chen; Meng Liu; Qidang Huang; Shaoling Zheng; Xin Guo; Weiming Deng; Tianwang Li
Journal:  Dis Markers       Date:  2021-06-12       Impact factor: 3.434

Review 9.  Adult-Onset Still's Disease: Novel Biomarkers of Specific Subsets, Disease Activity, and Relapsing Forms.

Authors:  Beatrice Maranini; Giovanni Ciancio; Marcello Govoni
Journal:  Int J Mol Sci       Date:  2021-12-11       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.